Top Page | English | 简体中文 | 繁體中文 | 한국어 | 日本語
Thursday, 3 March 2022, 18:29 HKT/SGT
Share:
Yeahka Donate 60,000 Antigen Rapid Test Kits Supporting Hong Kong's Fight Against COVID-19

HONG KONG, Mar 3, 2022 - (ACN Newswire) - Yeahka Limited ("Yeahka" or the "Company") (09923.HK) has announced a donation of 60,000 antigen rapid test kits to support Hong Kong's fight against the increasingly serious outbreak of Covid-19.

The antigen rapid test kits will be donated to Po Leung Kuk and distributed to the elderly and disabled through its elderly service units and rehabilitation service units respectively, helping them monitor their health status in real-time.

The fifth wave of the pandemic has proven challenging for Hong Kong, with the number of new daily COVID-19 infections hitting record highs. In the face of the severe pandemic situation, there is an increase in demand for pandemic prevention resources. Yeahka has been closely monitoring the pandemic situation in Hong Kong and hopes the initiative will help, sending love and care to the people in need.

About YEAHKA LIMITED (Stock Code: 9923.HK)
Yeahka, listed on the Main Board of Hong Kong Stock Exchange in 2020, is a leading payment-based technology platform dedicated to creating value for merchants and consumers by providing one-stop payment services and diversified technology-enabled business services. According to Analysys's report in 2022, Yeahka ranks No.1 in the non-bank, Independent QR code payment service market in China.



Topic: Press release summary Sectors: Cards & Payments, Enterprise IT
http://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2026 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.



Latest Press Releases
Hong Kong Book Fair, Sports and Leisure Expo and World of Snacks all open today  
July 15, 2026 23:32 HKT/SGT
LEQEMBI(R) Real-World LEADER Study Presented at AAIC(R) 2026 Finds Over 75% of Early Alzheimer's Patients Enrolled in the Study Remained Stable and Nearly 7% Improved Over an Average of 17 Months of Treatment  
Wednesday, July 15, 2026 11:18:00 PM
FDA Approves LEQEMBI IQLIK(R) (lecanemab-irmb) Subcutaneous Injection as an Initiation Dose for Early Alzheimer's Disease  
Wednesday, July 15, 2026 10:51:00 PM
Eisai Presents Latest Findings Showed Etalanetug Reduced Alzheimer's Disease Tau Tangle-Specific Plasma Biomarker MTBR-tau243 at Alzheimer's Association International Conference(R) (AAIC(R)) 2026  
Wednesday, July 15, 2026 10:21:00 PM
NEC develops world's first proprietary-AI technology to rapidly generate highly detailed 3D models solely from general-purpose camera footage while automatically removing unnecessary subjects  
Wednesday, July 15, 2026 9:53:00 PM
Hitachi Rail achieves EcoVadis platinum medal, ranking among the top 1% of companies worldwide for sustainability performance  
Wednesday, July 15, 2026 9:35:00 PM
AI Labs Launches AI-Powered Investment Intelligence Platform to Bring Advanced Technology Stock Analytics to Retail Investors  
July 15, 2026 21:20 HKT/SGT
Shoucheng Holdings (0697.HK) Expands AI Computing Infrastructure Portfolio with Strategic Investment in Shuoguang Precision  
July 15, 2026 16:49 HKT/SGT
IDC Releases Physical AI Map: 51World Emerges as the Only "Three-in-One" Software-Layer Benchmark Covering Models, Simulation, and Data  
July 15, 2026 14:21 HKT/SGT
VAP Group Unveils VAP Ventures to Back 100 Startups by 2030, Marking Its Next Chapter in Building the Global Innovation Ecosystem  
July 15, 2026 12:19 HKT/SGT
More Press release >>
 Events:
More >>
 News Alerts
Copyright © 2026 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: